EXPEDITION
- 2 sites in New Zealand
Na+/H+ Excahnge Inhibition to Prevent Coronary Events in Acute Cardiac Conditions. A double-blind, placebo controlled, multinational trial to investigate the effect of IV treatment with the Na+/H+ exchange inhibitor cariporide (HOE642) on all-cause mortality and non-fatal myocardial infarction in patients at risk of myocardial necrosis during and after coronary artery bypass graft (CABG) surgery.